More often than not, scientists are unable to reproduce medical research results. The lack of reproducibility is likely due to more complicated experiments as laboratory methods evolve, the use of different equipment and materials by different studies, the high number of variables present in a study, authors not presenting all information to other researchers, and […]
The National Human Genome Research Institute (NHGRI) has announced a four-year, $416 million plan to expand its Genome Sequencing Program. An initial amount of $86 million annually will support basic research, new initiatives and technological improvements at three large genome sequencing centers. For the first year, fiscal 2012, the Broad Institute, Washington University and Baylor […]
Metrohm sets itself apart from other companies. Its business structure is not one that many instrument firms choose to emulate, but it has served the company well for decades. In fact, the firm estimates its 2011 revenues to be CHF 300 million ($333.3 million = CHF 0.90 = $1). Metrohm is unique because of the […]
Third-quarter 2011 IBO Life Science Index sales grew 6.7%, 4.6% excluding currency, to $3,149.7 million. Operating profit improved 2.1% to $641.8 million, and operating margin slipped 90 basis points to 21.4% of sales. Fiscal fourth-quarter revenue for Becton Dickinson’s BD Biosciences division grew 9.6%, 4.7% excluding currency, to $354.2 million to account for 17% of […]
Newark, DE 11/11/11; London, UK 11/11/11; Newark, DE 12/9/11; London, UK 12/9/11—Antibody solutions firm SDIX has sold its Water Quality division to Modern Water, a publicly held UK firm that provides technology for water desalination and monitoring, for $4.5 million. The sale includes the division’s intellectual property, inventory, commercial contracts, equipment and staff. The division […]
Gaithersburg, MD 12/14/11—Ocimum Biosolutions announced that it has retained Burrill & Company to evaluate strategic alternatives for its Gene Logic business, which could include the sale of its operations or assets. Gene Logic provides genomics services and informatics solutions. Burrill & Company is identifying buyers to bid on the company’s assets before January 6, 2012.
Amsterdam, The Netherlands 12/8/11—Scientific publisher Elsevier has acquired the business assets of Ariadne Genomics for an undisclosed amount. Ariadne Genomics provides pathway analysis tools and semantic technologies for life science researchers, including the Pathway Studio data mining and visualization solution. “Ariadne Genomics’ pathway analysis tools and semantic technologies integrate research findings from across multiple content […]
Corning, NY 12/1/11—Corning has acquired Mediatech, including its KD Medical subsidiary, for an undisclosed amount. Mediatech develops, manufactures and sells cell culture media and molecular biology reagents related to tissue and cell culture applications, including products under the cellgro brand. “By providing customers worldwide with greater access to Mediatech’s cellgro product portfolio, this acquisition supports […]
Santa Clara, CA 12/1/11—Agilent Technologies has announced the acquisition of two firms. Financial details were not provided. Agilent has acquired Halo Genomics, whose HaloPlex technology provides sequence-selective sample preparation in next-generation sequencing (NGS). “Halo Genomics’ unique technology and talented R&D team will expand Agilent’s solutions for emerging sequencing applications and accelerate our entry into the […]
On November 30, the European Commission unveiled its proposal for Horizon 2020, the EU’s €79,271 million ($105,713 million = €0.75 = $1) R&D program for 2014 through 2020. The program aims to unite existing EU research programs, simplify and streamline EU funding for R&D, and promote strategic priorities. The program encompasses major EU mechanisms for […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
